FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

INTRON A (Interferon alfa-2b) Recombinant for Injection
Status: Discontinuation
»Therapeutic Categories: Antiviral; Oncology

Expand all

Merck Sharp & Dohme Corp. (New 09/12/2019)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
INTRON A Powder for Injection (Interferon alfa-2b) 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4350-01) 09/12/2019 To be discontinued in 2022
INTRON A Powder for Injection (Interferon alfa-2b) 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent ((NDC 0085-4351-01)) 09/12/2019 To be discontinued in 2022
INTRON A Powder for Injection (Interferon alfa-2b) 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01) 09/12/2019 To be discontinued in 2022
INTRON A Solution for Injection (Interferon alfa-2b) 25 million IU multidose vial (32 million IU per 3.2 mL per vial); boxes containing 1 vial of INTRON A Solution for Injection (NDC 0085-1168-01) 09/12/2019 To be discontinued in 2021
INTRON A Solution for Injection (Interferon alfa-2b) 25 million IU multidose vial (32 million IU per 3.2 mL per vial); boxes containing 1 vial of INTRON A Solution for Injection (NDC 0085-1133-01) 09/12/2019 To be discontinued in 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English